LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68,788 | -45.4% | 1,148 | -34.3% | 0.00% | -50.0% |
Q2 2023 | $126,031 | -4.2% | 1,748 | -2.2% | 0.00% | -33.3% |
Q1 2023 | $131,525 | +10.4% | 1,788 | +0.3% | 0.00% | +50.0% |
Q4 2022 | $119,104 | -22.7% | 1,783 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $154,000 | -5.5% | 1,783 | -2.6% | 0.00% | 0.0% |
Q2 2022 | $163,000 | -23.1% | 1,831 | -2.9% | 0.00% | 0.0% |
Q1 2022 | $212,000 | -35.2% | 1,886 | -11.0% | 0.00% | -40.0% |
Q4 2021 | $327,000 | +15.1% | 2,120 | +3.9% | 0.01% | +25.0% |
Q3 2021 | $284,000 | +11.4% | 2,040 | +4.9% | 0.00% | 0.0% |
Q2 2021 | $255,000 | -12.4% | 1,945 | +2.0% | 0.00% | -20.0% |
Q1 2021 | $291,000 | -19.2% | 1,906 | -47.3% | 0.01% | -16.7% |
Q4 2020 | $360,000 | +11.1% | 3,615 | +6.2% | 0.01% | 0.0% |
Q3 2020 | $324,000 | -12.4% | 3,404 | +2.9% | 0.01% | -25.0% |
Q2 2020 | $370,000 | -79.7% | 3,307 | -86.8% | 0.01% | -83.3% |
Q1 2020 | $1,821,000 | -33.0% | 25,042 | -3.9% | 0.05% | -15.8% |
Q4 2019 | $2,718,000 | -0.5% | 26,063 | -5.0% | 0.06% | -5.0% |
Q3 2019 | $2,731,000 | -16.8% | 27,433 | -4.6% | 0.06% | -18.9% |
Q2 2019 | $3,282,000 | -48.0% | 28,755 | -42.7% | 0.07% | -50.7% |
Q1 2019 | $6,309,000 | +1614.4% | 50,189 | +1750.6% | 0.15% | +1400.0% |
Q4 2018 | $368,000 | -25.7% | 2,712 | +50.5% | 0.01% | -16.7% |
Q3 2018 | $495,000 | +124.0% | 1,802 | -1.0% | 0.01% | +50.0% |
Q2 2017 | $221,000 | +29.2% | 1,821 | +13.0% | 0.01% | +33.3% |
Q1 2017 | $171,000 | +69.3% | 1,611 | +62.6% | 0.01% | +50.0% |
Q4 2016 | $101,000 | +23.2% | 991 | +23.7% | 0.00% | 0.0% |
Q3 2016 | $82,000 | -2.4% | 801 | +14.3% | 0.00% | 0.0% |
Q2 2016 | $84,000 | +31.2% | 701 | +17.0% | 0.00% | +33.3% |
Q1 2016 | $64,000 | -1.5% | 599 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $65,000 | +35.4% | 599 | +6.2% | 0.00% | +50.0% |
Q3 2015 | $48,000 | -15.8% | 564 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $57,000 | +32.6% | 564 | 0.0% | 0.00% | +50.0% |
Q1 2015 | $43,000 | +72.0% | 564 | +20.0% | 0.00% | +100.0% |
Q4 2014 | $25,000 | +8.7% | 470 | -5.6% | 0.00% | 0.0% |
Q3 2014 | $23,000 | +4.5% | 498 | +38.7% | 0.00% | 0.0% |
Q2 2014 | $22,000 | +29.4% | 359 | +41.3% | 0.00% | 0.0% |
Q1 2014 | $17,000 | +41.7% | 254 | +8.1% | 0.00% | 0.0% |
Q4 2013 | $12,000 | +50.0% | 235 | +23.7% | 0.00% | – |
Q3 2013 | $8,000 | – | 190 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |